The groundbreaking success of Viagra undeniably reshaped the pharmaceutical landscape, but betting in companies strongly reliant on generic versions presents a challenging picture. While early profits were impressive, the cessation of patents and the rise of less expensive alternatives have weakened market share. Thus, a thorough analysis of ongoin